Given the current COVID-19-driven stock market volatility, high common stock leverage among each of Japan's major non-life insurers brings systematic equity price risk into greater consideration - according an AM Best report titled 'Japan Non-Life: Robust Capitalisation to Weather Stock Market Volatility'.